Transdermal Drug Delivery Market 2016 – Industry Growth, Competitive Analysis, Future Prospects And Forecast 2024

Research Nester has recently announced new market demand assessment research titled “Transdermal Drug Delivery Market –Demand, Opportunity, Growth, Future Prospects and Competitive Analysis, 2016 – 2024”. The global Transdermal Drug Delivery Market study provides a granular data and in-depth analysis on the current and future market situations that are crucial for the existing &new players in the market.   Transdermal Drug Delivery Market industry research is based on key factors like demand & supply analysis, commercial activities, research investments, pricing analysis, government initiatives & guidelines, driving forces in the market, roadblocks and segmentation based on the product viability.

“Global Transdermal Drug Delivery Market: Global Future Outlook (2016-2024) Demand Analysis & Opportunity Evaluation” delivers detailed overview of the global transdermal drug delivery market in terms of market segmentation by technology, by application, and by region.

Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.

Global transdermal drug delivery market is segmented on the basis of application into cardiovascular, CNS, pain management, dermatology and others. Further, global cardiovascular transdermal drug delivery market is anticipated to reach USD 1,911.3 Million by the end of 2024. This growth of cardiovascular transdermal drug segment can be attributed to growing number of patients with cardiovascular disorders. This growth in cardiovascular segment is making headway for the expansion of the transdermal drug delivery market across all regions. Further, cardiovascular transdermal drug delivery segment is projected to achieve Y-o-Y growth rate of 9.9% in 2024 as compared to previous year.

Global transdermal drug delivery market reached at remarkable revenue in 2016 by registering a notable CAGR across the globe. Moreover, the market is expected to garner USD 7,358.0 Million by the end of 2024. Moreover, the global market is projected to grow on the back of Factors such as growing pharmaceutical industry, increasing global population, rising number of chronic patients.  Besides, high adoption rate of advance technologies in developed regions is also expected to impel the growth of transdermal drug delivery market across the globe.

In application segment, cardiovascular segment has dominated the global transdermal drug delivery market with a market share of 23.5% in 2016 and anticipated to flourish at a CAGR of 8.8% over the forecast period. With growing number of patients with cardiovascular disorders, cardiovascular segment is making headway for the expansion of the transdermal drug delivery market.

Get the Sample of this Report @

Rising Prevalence of Diseases

Factors such as growth in chronic disease prevalence and increasing geriatric population across the globe are benefitting the growth of transdermal drug delivery market. Apart from this, growing spending on healthcare by the population is anticipated to positively impact the growth of the market

Wide Application Possibilities

Transdermal drug delivery devices such as patch find their major application in insulin delivery to diabetic patients. Further, rising number of diabetic patients across the globe are likely to increase the consumption of transdermal drug delivery patch which in turn is expected to drive the growth of the market.

Request For Full Report-

However, side effects from transdermal drug delivery are anticipated to restrict the growth of transdermal drug delivery market. Further, skin irritation associated with the use of transdermal drug delivery is anticipated to restrain the growth of global transdermal drug delivery market.

This report also provides the existing competitive scenario of some of the key players of the global Transdermal Drug Delivery Market which includes company profiling of Antares Pharma Inc., Bayer AG, ANI Pharmaceuticals Inc., Novartis AG, Janssen Pharmaceuticals Inc. and other notable players. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global transdermal drug delivery market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.

About Us

Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision so as to avoid future uncertainties.

Contact Us:

AJ Daniel


U.S. Phone: +1 646 586 9123

U.K. Phone: +44 203 608 5919

Research Nester is a one-stop service provider, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives to make wise decisions for their future investment and expansion by providing them qualitative market insights and strategies while avoiding future uncertainties. We believe in honesty and sheer hard work that we trust is reflected in our work ethics. Our vision is not just limited to gain the trust of our clients but also to be equally respected by our employees and being appreciated by the competitors.

Leave a Reply